Shares of Pharma Mar, S.A. (OTCMKTS:PHMMF – Get Free Report) reached a new 52-week high during trading on Tuesday . The company traded as high as $88.24 and last traded at $88.24, with a volume of 4000 shares. The stock had previously closed at $75.00.
Pharma Mar Price Performance
The company has a current ratio of 2.55, a quick ratio of 2.01 and a debt-to-equity ratio of 0.14. The business’s 50 day moving average is $79.25 and its 200 day moving average is $60.13.
About Pharma Mar
Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.
See Also
- Five stocks we like better than Pharma Mar
- Insider Trades May Not Tell You What You Think
- 3 Consumer Stocks Call Option Traders Are Betting Big On
- Manufacturing Stocks Investing
- Duolingo: An Unexpected Benefactor From the TikTok Ban
- The How and Why of Investing in Gold Stocks
- Trump Index: 6 Companies Linked to Trump’s Cabinet Worth Watching
Receive News & Ratings for Pharma Mar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Mar and related companies with MarketBeat.com's FREE daily email newsletter.
